Fig. 5From: Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysisRisk of HBVr among HBsAg positive patients with or without antiviral prophylaxis. HBVr hepatitis B virus reactivation, HBsAg hepatitis B surface antigen, ES effect size, CI confidence intervalBack to article page